Compass Minerals (CMP) Q4 2025 earnings review
Fiscal 2025: The 'Clean Up' Year Pays Off in Cash
Compass Minerals delivered a pivotal Q4 that validated its painful 'back-to-basics' restructuring. While net results remain negative (-$7.2M), the trajectory has sharply reversed from the deep losses of 2024. The headline story is the massive swing in operating cash flow ($198M vs $14M YoY) driven by aggressive inventory liquidation. Management successfully curtailed production to clear excess salt, reducing net debt by $125M. However, FY26 guidance tempers enthusiasm: while margins are set to recover as production ramps back up, revenue is expected to contract due to a conservative volume outlook.
🐂 Bull Case
The strategy worked: Operating Cash Flow surged to $197.7M in FY25 from just $14.4M in FY24. By intentionally under-producing and selling off inventory, CMP unlocked nearly $150M in working capital and paid down 14% of its total debt.
The segment has flipped from a bleed to a contributor. Q4 Operating Income reached $6.2M (vs. a $29.7M loss in 24Q4). FY25 Adjusted EBITDA more than doubled to $34.9M, proving the unit can be profitable even with modest revenue growth.
🐻 Bear Case
FY26 guidance implies a revenue decline. The company projects Salt sales volumes to drop ~8% (midpoint 10.0M tons vs 10.8M actual in FY25). While pricing is up slightly, it won't fully offset the volume drop.
FY25 Salt Adjusted EBITDA per ton fell 18% to $20.20 due to unabsorbed fixed costs from production curtailments. While FY26 should improve, the company must now prove it can restore margins without re-bloating inventory.
⚖️ Verdict: ⚪
Neutral. The balance sheet repair is commendable and reduces insolvency risk, but the growth story is absent. CMP is trading revenue for margin stability in FY26. Investable for the turnaround in profitability, but limited upside until volumes stabilize.
Key Themes
Massive Inventory Liquidation Generating Cash
Reversing. The primary financial driver of FY25 was the deliberate decision to stop mining and sell from the pile. North American highway deicing inventory value dropped 33% and volume dropped 36%. This painful operational move liberated cash flow, allowing a $125M debt reduction. This trend is now complete; FY26 will see a return to normalized production.
Conservative Volume Guidance for FY26
Decelerating. Management introduced a 'refined' forecasting process for FY26, guiding for total salt volumes of 9.65-10.3M tons. This is a significant step down from the 10.85M tons achieved in FY25. Midpoint revenue guidance of $995M for the Salt segment implies a ~3% contraction vs FY25 actuals ($1,022M), suggesting management is baking in mild weather or market share caution.
Plant Nutrition Profitability Restoration
Accelerating. The segment has structurally improved. Despite Q4 revenue being flat (-1% YoY), Adjusted EBITDA swung from -$3.7M in 24Q4 to +$13.5M in 25Q4. Margins expanded to 32% (Adj EBITDA margin) driven by lower production costs and improved distribution. FY26 guidance expects to hold these gains with $31-36M in EBITDA.
Salt Pricing Power Remains Muted
Stable. Pricing is not a major growth lever currently. Q4 Salt pricing was down 1% YoY due to mix. For FY26, management guides North American highway deicing contract prices up only 2-4%. This barely covers inflation, putting the onus entirely on cost control (fixed cost absorption) to drive margin expansion.
Unit Cost Improvement Expected in FY26
Reversing. In FY25, Salt Adjusted EBITDA per ton dropped to ~$20.20 (from ~$24.50 in FY24) because the mines were idle (curtailment), leading to high unabsorbed fixed costs per unit. In FY26, as production ramps back up to replenish stock, fixed cost absorption will improve, driving the forecasted Salt EBITDA growth ($225M-$255M) despite lower sales volumes.
Other KPIs
Accelerating significantly from $15.6M in 24Q4. The improvement was driven by the Salt segment ($40M vs $38M) and a massive swing in Plant Nutrition ($13.5M vs -$3.7M). Corporate costs also normalized following the exit of the Fortress business.
Reversing. Debt peaked over $900M in FY24. The reduction of $125M YoY (14%) significantly de-risks the equity. Leverage ratios are improving as EBITDA stabilizes and debt falls.
Accelerating. Up 12% YoY. Volume growth of 13% offset a slight 1% price decline. Highway deicing volumes were up 20% in the quarter, signaling some early stocking activity or normalization after the mild 2024 winter.
Guidance
Accelerating. The midpoint ($220M) implies ~11% growth over FY25's reported $198.8M. Growth is driven by improved unit costs in Salt (better fixed cost absorption) and sustained profitability in Plant Nutrition, despite top-line headwinds.
Decelerating/Contracting. Midpoint ($995M) is below FY25 actuals of $1,022.5M. This confirms a revenue contraction year, driven by lower volume expectations (down ~8%) only partially offset by price hikes (+2-4%).
Accelerating. Up from the suppressed level of $69.7M in FY25. The company deferred spend in FY25 to preserve cash; FY26 represents a return to maintenance levels plus necessary sustainment for the Ogden solar ponds.
Stable. The midpoint implies a 15% improvement YoY (excluding the one-time Fortress gain in FY25). This reflects the structural headcount reductions and 'leaner' operating model implemented over the last 12 months.
Key Questions
Forecasting Methodology Change
FY26 Salt volume guidance is down ~8% versus FY25 actuals. Is this purely conservatism based on 'refined forecasting,' or are you seeing competitive share loss in the bid season?
Capital Allocation Priorities
Now that net debt has been reduced by $125M and you are generating cash again, how do you prioritize further deleveraging versus the increased CapEx budget for FY26?
Unit Cost Dynamics
You mentioned improved fixed cost absorption for FY26. Can you quantify the expected improvement in Salt EBITDA per ton compared to the depressed $20.20 level seen in FY25?
Plant Nutrition Ceiling
Plant Nutrition EBITDA has recovered to ~$35M. Is this the new run-rate ceiling given revenue is expected to be flat/down in FY26, or is there further margin expansion available?